Q2 2019 Holdings
Filed 2019-08-14 | 81 holdings | $224.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Castlight Health Inc(CSLT1EUR) | CL B | 14862Q100 | $33 | 10,229 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $135 | 16,260 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $220 | 3,400 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $220 | 10,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $231 | 2,740 | 0.0% |
| LHC Group Inc(LHCGUSD) | COM | 50187A107 | $259 | 2,166 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $264 | 22,236 | 0.0% |
| Flexion Therapeutics Inc | COM | 33938J106 | $266 | 21,630 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $274 | 11,400 | 0.0% |
| Amedisys Inc(AMED) | COM | 023436108 | $282 | 2,320 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $313 | 6,252 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $316 | 16,720 | 0.0% |
| Endologix Inc(ELGXEUR) | COM NEW | 29266S304 | $570 | 78,755 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $1.3K | 254,590 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $1.4K | 737,550 | 0.0% |
| Forty Seven Inc(FTSVEUR) | COM | 34983P104 | $2.5K | 234,000 | 0.0% |
| Avedro Inc(219) | COM | 05355N109 | $4.2K | 216,200 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $5.5K | 248,600 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $8.1K | 244,100 | 0.0% |
| Biomarin Pharmaceutical Inc(BMRN)Call | COM | 09061G101 | $8.6K | 100,000 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $8.8K | 375,375 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $9.0K | 292,734 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $9.9K | 188,000 | 0.0% |
| Logicbio Therapeutics Inc | COM | 54142F102 | $10.6K | 814,898 | 0.0% |
| Personalis Inc(PSNL) | COM | 71535D106 | $10.9K | 400,000 | 0.0% |
| Hookipa Pharma Inc | COM | 43906K100 | $12.7K | 1,891,879 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $15.4K | 3,558,388 | 0.0% |
| Morphosys AG | SPONSORED ADS | 617760202 | $17.7K | 733,699 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $21.5K | 1,140,306 | 0.0% |
| Vapotherm Inc | COM | 922107107 | $22.1K | 959,539 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $22.4K | 1,168,802 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $22.5K | 3,138,365 | 0.0% |
| Alder Biopharmaceuticals Inc | NOTE 2.500% 2/0 | 014339AA3 | $23.2K | $25,000,000 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $23.9K | 2,008,447 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $24.0K | 168,387 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $24.7K | 1,796,477 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $25.7K | 1,799,216 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $25.8K | 172,100 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $27.2K | 740,671 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $27.3K | 878,403 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $29.8K | 1,021,808 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $30.3K | 13,954,794 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $30.5K | 423,987 | 0.0% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $30.7K | 461,880 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $32.2K | 2,197,003 | 0.0% |
| Axonics Modulation Tech Inc(AXNX*) | COM | 05465P101 | $33.3K | 813,500 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $33.5K | 3,620,376 | 0.0% |
| Xeris Pharmaceuticals Inc | COM | 98422L107 | $34.3K | 3,000,641 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $34.4K | 609,658 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $34.6K | 141,901 | 0.0% |